The present invention relates to electrosurgery and in particular, to electrosurgical bipolar forceps.
The field of electrosurgery includes a number of loosely related surgical techniques which have in common the application of electrical energy to modify the structure or integrity of patient tissue. Electrosurgical procedures usually operate through the application of very high frequency currents to cut or ablate tissue structures, where the operation can be monopolar or bipolar. Monopolar techniques rely on a separate electrode for the return of current that is placed away from the surgical site on the body of the patient, and where the surgical device defines only a single electrode pole that provides the surgical effect. Bipolar devices comprise two or more electrodes on the same support for the application of current between their surfaces.
Electrosurgical procedures and techniques are particularly advantageous because they generally reduce patient bleeding and trauma associated with cutting operations. Additionally, electrosurgical ablation procedures, where tissue surfaces and volume may be reshaped, cannot be duplicated through other treatment modalities.
Radiofrequency (RF) energy is used in a wide range of surgical procedures because it provides efficient tissue resection and coagulation and relatively easy access to the target tissues through a portal or cannula. Conventional monopolar high frequency electrosurgical devices typically operate by creating a voltage difference between the active electrode and the target tissue, causing an electrical arc to form across the physical gap between the electrode and tissue. At the point of contact of the electric arcs with tissue, rapid tissue heating occurs due to high current density between the electrode and tissue. This high current density causes cellular fluids to rapidly vaporize into steam, thereby producing a “cutting effect” along the pathway of localized tissue heating. Thus, the tissue is parted along the pathway of evaporated cellular fluid, inducing undesirable collateral tissue damage in regions surrounding the target tissue site. This collateral tissue damage often causes indiscriminate destruction of tissue, resulting in the loss of the proper function of the tissue. In addition, the device does not remove any tissue directly, but rather depends on destroying a zone of tissue and allowing the body to eventually remove the destroyed tissue.
Present electrosurgical devices used for cutting and dissection, such as monopolar electrocautery instruments, are able to cut and coagulate tissue, but cause high levels of collateral thermal damage to surrounding tissue. This limits the use of the monopoloar electrocautery devices to relatively “safe” areas away from sensitive structures such as blood vessels and nerves. In comparison, a traditional bipolar forceps may be used routinely for coagulation of small to medium sized vessels and may be preferred over monopolar electrocautery devices in the vicinity of sensitive structures because use of traditional bipolar forceps typically results in much less collateral thermal damage due to the localization of energy around the active and return electrodes at the tip of the device. However, these bipolar forceps do not have the ability to effectively cut or dissect tissue, requiring a physician needing to cut coagulated tissue to select another instrument (scissors, monopolar electrocautery, etc.) to complete the dissection. The necessity of so many instruments for one surgical procedure requires frequent switching between instruments, adding significant time to the procedure and frustration for the physician. Additionally, vessel sealing solutions presently exist for use where coagulation is desired and can typically involve use of sutures, clips, or energy-based devices to heat, seal, and/or cut large blood vessels. However, these devices are limited in that they do not provide fine dissection of tissue.
Accordingly, improved systems and methods in the configuration of surgical forceps are still desired with the ability to perform fine dissection of tissue, while preserving the ability to coagulate vessels and tissue. In particular, improved systems designed to integrate plasma-based cutting combined with effective coagulation abilities into a pair of bipolar forceps would provide a competitive advantage.
For a detailed description of exemplary embodiments, reference will now be made to the accompanying drawings in which:
Certain terms are used throughout the following description and claims to refer to particular system components. As one skilled in the art will appreciate, companies that design and manufacture electrosurgical systems may refer to a component by different names. This document does not intend to distinguish between components that differ in name but not function.
In the following discussion and in the claims, the terms “including” and “comprising” are used in an open-ended fashion, and thus should be interpreted to mean “including, but not limited to . . . ” Also, the term “couple” or “couples” is intended to mean either an indirect or direct connection. Thus, if a first device couples to a second device, that connection may be through a direct connection or through an indirect electrical connection via other devices and connections.
Reference to a singular item includes the possibility that there are plural of the same items present. More specifically, as used herein and in the appended claims, the singular forms “a,” “an,” “said” and “the” include plural references unless the context clearly dictates otherwise. It is further noted that the claims may be drafted to exclude any optional element. As such, this statement serves as antecedent basis for use of such exclusive terminology as “solely,” “only” and the like in connection with the recitation of claim elements, or use of a “negative” limitation. Lastly, it is to be appreciated that unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs.
“Active electrode” shall mean an electrode of an electrosurgical wand which produces an electrically-induced tissue-altering effect when brought into contact with, or close proximity to, a tissue targeted for treatment.
“Return electrode” shall mean an electrode of an electrosurgical wand which serves to provide a current flow path for electrons with respect to an active electrode, and/or an electrode of an electrical surgical wand which does not itself produce an electrically-induced tissue-altering effect on tissue targeted for treatment.
A fluid conduit said to be “within” an elongate shaft shall include not only a separate fluid conduit that physically resides within an internal volume of the elongate shaft, but also situations where the internal volume of the elongate shaft is itself the fluid conduit.
Where a range of values is provided, it is understood that every intervening value, between the upper and lower limit of that range and any other stated or intervening value in that stated range is encompassed within the invention. Also, it is contemplated that any optional feature of the inventive variations described may be set forth and claimed independently, or in combination with any one or more of the features described herein.
All existing subject matter mentioned herein (e.g., publications, patents, patent applications and hardware) is incorporated by reference herein in its entirety except insofar as the subject matter may conflict with that of the present invention (in which case what is present herein shall prevail). The referenced items are provided solely for their disclosure prior to the filing date of the present application. Nothing herein is to be construed as an admission that the present invention is not entitled to antedate such material by virtue of prior invention.
Before the various embodiments are described in detail, it is to be understood that this invention is not limited to particular variations set forth herein as various changes or modifications may be made, and equivalents may be substituted, without departing from the spirit and scope of the invention. As will be apparent to those of skill in the art upon reading this disclosure, each of the individual embodiments described and illustrated herein has discrete components and features which may be readily separated from or combined with the features of any of the other several embodiments without departing from the scope or spirit of the present invention. In addition, many modifications may be made to adapt a particular situation, material, composition of matter, process, process act(s) or step(s) to the objective(s), spirit or scope of the present invention. All such modifications are intended to be within the scope of the claims made herein.
In some embodiments the forceps 102 has one or more fluid conduits operable to be coupled to externally accessible tubular members (for access to a fluid receptacle or wall suction). As illustrated, the forceps 102 has a flexible tubular member 116 and a second flexible tubular member 118. In some embodiments, the flexible tubular member 116 is used to provide electrically conductive fluid (e.g., saline) to the distal end portion 105 of the leg 104. Likewise in some embodiments, flexible tubular member 118 is used to provide aspiration to the distal end portion 107 of the leg 106.
The electrosurgical system 100 of the various embodiments may have a variety of operational modes. One such mode employs Coblation® technology. In particular, the assignee of the present disclosure is the owner of Coblation technology. Coblation technology involves the application of a radio frequency (RF) signal between one or more active electrodes and one or more return electrodes of the wand 102 to develop high electric field intensities in the vicinity of the target tissue. The electric field intensities may be sufficient to vaporize an electrically conductive fluid over at least a portion of the one or more active electrodes in the region between the one or more active electrodes and the target tissue. The electrically conductive fluid may be inherently present in the body, such as blood, or in some cases extracelluar or intracellular fluid. In other embodiments, the electrically conductive fluid may be a liquid or gas, such as isotonic saline. In some embodiments, such as surgical procedures on a disc between vertebrae, the electrically conductive fluid is delivered in the vicinity of the active electrode and/or to the target site by the wand 102, such as by way of the internal passage and flexible tubular member 116.
When the electrically conductive fluid is heated to the point that the atoms of the fluid vaporize faster than the atoms recondense, a gas is formed. When sufficient energy is applied to the gas, the atoms collide with each other causing a release of electrons in the process, and an ionized gas or plasma is formed (the so-called “fourth state of matter”). Stated otherwise, plasmas may be formed by heating a gas and ionizing the gas by driving an electric current through the gas, or by directing electromagnetic waves into the gas. The methods of plasma formation give energy to free electrons in the plasma directly, electron-atom collisions liberate more electrons, and the process cascades until the desired degree of ionization is achieved. A more complete description of plasma can be found in Plasma Physics, by R. J. Goldston and P. H. Rutherford of the Plasma Physics Laboratory of Princeton University (1995), the complete disclosure of which is incorporated herein by reference.
As the density of the plasma becomes sufficiently low (i.e., less than approximately 1020 atoms/cm3 for aqueous solutions), the electron mean free path increases such that subsequently injected electrons cause impact ionization within the plasma. When the ionic particles in the plasma layer have sufficient energy (e.g., 3.5 electron-Volt (eV) to 5 eV), collisions of the ionic particles with molecules that make up the target tissue break molecular bonds of the target tissue, dissociating molecules into free radicals which then combine into gaseous or liquid species. Often, the electrons in the plasma carry the electrical current or absorb the electromagnetic waves and, therefore, are hotter than the ionic particles. Thus, the electrons, which are carried away from the target tissue toward the active or return electrodes, carry most of the plasma's heat, enabling the ionic particles to break apart the target tissue molecules in a substantially non-thermal manner.
By means of the molecular dissociation (as opposed to thermal evaporation or carbonization), the target tissue is volumetrically removed through molecular dissociation of larger organic molecules into smaller molecules and/or atoms, such as hydrogen, oxygen, oxides of carbon, hydrocarbons and nitrogen compounds. The molecular dissociation completely removes the tissue structure, as opposed to dehydrating the tissue material by the removal of liquid within the cells of the tissue and extracellular fluids, as occurs in related art electrosurgical desiccation and vaporization. A more detailed description of the molecular dissociation can be found in commonly assigned U.S. Pat. No. 5,697,882, the complete disclosure of which is incorporated herein by reference.
In addition to the Coblation mode, the electrosurgical system 100 of
The energy density produced by electrosurgical system 100 at the distal end of the wand 102 may be varied by adjusting a variety of factors, such as: the number of active electrodes; electrode size and spacing; electrode surface area; asperities and/or sharp edges on the electrode surfaces; electrode materials; applied voltage; current limiting of one or more electrodes (e.g., by placing an inductor in series with an electrode); electrical conductivity of the fluid in contact with the electrodes; density of the conductive fluid; and other factors. Accordingly, these factors can be manipulated to control the energy level of the excited electrons. Because different tissue structures have different molecular bonds, the electrosurgical system 100 may be configured to produce energy sufficient to break the molecular bonds of certain tissue but insufficient to break the molecular bonds of other tissue. For example, fatty tissue (e.g., adipose) has double bonds that require an energy level higher than 4 eV to 5 eV (i.e., on the order of about 8 eV) to break. Accordingly, the Coblation® technology in some operational modes does not ablate such fatty tissue; however, the Coblation technology at the lower energy levels may be used to effectively ablate cells to release the inner fat content in a liquid form. Other modes may have increased energy such that the double bonds can also be broken in a similar fashion as the single bonds (e.g., increasing voltage or changing the electrode configuration to increase the current density at the electrodes).
A more complete description of the various phenomena can be found in commonly assigned U.S. Pat. Nos. 6,355,032; 6,149,120 and 6,296,136, the complete disclosures of which are incorporated herein by reference.
Referring now to
Return electrode 204 is preferably a semi-annular member defining the exterior of distal end portion 107, and a distal portion of return electrode 204 is preferably exposed. At least a proximal portion of return electrode 204 is disposed within an electrically insulative sheath 206, which is typically formed as one or more electrically insulative sheaths or coatings, such as polytetrafluoroethylene, polyimide, and the like. The provision of the electrically insulative sheath 206 encircling over a portion of return electrode 204 prevents direct electrical contact between return electrode 204 and any adjacent body structure or the surgeon. Such direct electrical contact between a body structure (e.g., vessel) and an exposed common electrode member 204 could result in unwanted heating and necrosis of the structure at the point of contact causing necrosis. Return electrode 204 is preferably formed from an electrically conductive material, usually metal, which is selected from the group consisting of stainless steel alloys, platinum or its alloys, titanium or its alloys, molybdenum or its alloys, and nickel or its alloys.
Forceps 102 are operable in manner consistent with similar grasping-type devices, in that concurrent pressure applied to the outer surface of each the legs 104, 106 actuates the legs 104, 106, and particularly the distal end portions 105, 107, toward one another. As such, the legs 104, 106 of forceps 102 may be selectively positioned in either an open position (i.e., legs 104, 106 are separated by some distance) as shown in
In addition, in certain embodiments the inside edge of active electrode 202 may be temporarily insulated when forceps 102 are configured in the closed position, which is the preferential position when forceps 102 are used for cutting. The placement of additional insulation on the inside edge of active electrode 202 helps prevent plasma from forming on that surface, enabling plasma to preferentially form on the outside edge and tip of active electrode 202. In certain embodiments, the insulative material could be mounted on return electrode 204, so that it covers active electrode 202 when the forceps 102 are in the closed position. Alternatively, the placement of the additional insulation may be on distal tip 105 and arranged to create a staggered effect as compared to the exposed surface of return electrode 204 on distal tip 107, where the insulated surface on leg 104 extends farther distally than the insulated surface of leg 106 (see
As discussed above, the forceps 102 is ideally configured for plasma formation and cutting operation when disposed in its closed position. In the closed position, active electrode 202 provides for fine dissection particularly at its most distal tip 203. However, the outside edge of active electrode may also be suitably utilized for plasma-mediated tissue dissection when activated in the closed position. It also follows that plasma formation and the ability to cut tissue adjacent to active electrode 202 is possible when the forceps is configured in the open position. For example, a physician may grasp a band of tissue between legs 104, 106, and then activate the plasma initiation on the surface of active electrode 202 to effective cut and sever the band of engaged tissue.
In some embodiments saline is delivered to the area of forceps 102 placed adjacent to the surgical field, possibly to aid in plasma creation. Specifically, forceps 102 may have integrated suction and saline delivery for added functionality. Saline delivery is required for optimal formation of plasma, but it also can be used to help flush the surgical field if blood is encountered without the use of an external syringe. Referring to
More particularly, saline delivery is accomplished via discharge aperture 208, which is integrated on the inside edge of the active electrode 202 and allows the saline to wick down between distal end portions 105, 107 to form a fluid meniscus between the active and return electrodes. When operating the forceps 102 in closed position, it is preferable that saline delivery provide good wetting of the active and return electrodes so that a saline meniscus forms between distal end portions 105, 107. This meniscus is maintained and replenished by the saline delivery and kept in balance with integrated suction at the distal end of the return electrode. The saline also wicks best to distal end portions 105, 107 when there is a slight angle between distal end portions 105, 107, with the narrowest portion being present at the most distal end. This helps takes advantage of capillary action to draw the fluid electrodes for better wetting and plasma formation at active electrode 202.
In yet still further embodiments, aspiration is provided at the area of the forceps 102 placed adjacent to the surgical field.
Integrated suction via suction port 207 for evacuating the saline helps maintain a dry field for identification of tissue and fine dissection. Integrated suction also allows rapid evacuation of blood from a bleeding vessel to localize the origin of the bleeding for effective coagulation application. Suction port 207 is preferentially positioned at the distal end of the return electrode 204, so that suction helps draw saline to the tip for good wetting and plasma formation, and also optimally positioned to evacuate fluids from the surgical field (e.g., saline, blood). In certain embodiments, discharge aperture 208 and suction port 207 may be integrated on the same legs of forceps 102, or swapped to the opposing sides as current described.
As shown for example in
The ergonomic configuration forceps 102 affords some unique tissue manipulation and visualization abilities versus other surgical instruments. This includes the ability to open/close legs 104, 106 to grasp tissue or influence the extent of thermal penetration. The preferred length of legs 104, 106 also provide good visualization of the targeted tissue by providing a clear view between distal end portions 105, 107 for precise manipulation and positioning. The forceps 102 can be used similar to other bipolar forceps for coagulation of small vessels and tissue by either positioning the distal end portions 105, 107 with a slight gap on the targeted tissue, or by grasping a vessel or band of tissue, or even sliding the distal end portions 105, 107 along a band of tissue or vessel to provide hemostasis. In addition to coagulation, forceps 102 have the unique ability to perform plasma-mediated cutting and fine dissection of tissue and vessels when activated in ablate/cut mode.
Referring now to
Upon engagement of the spring pin 302 within detent 304, a first follower arm of spring pin 302 is forced into the dual-track cam system of detent 304 to secure spring pin 302 within detent 304. A subsequent compression of the legs 104, 106 releases a second follower arm of the spring pin 302 from engagement within the detent 304. The dual-track cam system of detent 304 and its interplay with the two follower arms of spring pin 302 that engage in the tracks at different positions provide a robust latching mechanism for repeated use. The mechanism can also be made primarily of plastic or other materials to provide an insulating layer between the active and return electrode legs.
In this manner, the forceps may be closed and opened by application of a first, and a second push. Each push, in combination with tension from the spring, and the dual track system, locks and unlocks the forceps' legs.
The above discussion is meant to be illustrative of the principles and various embodiments of the present invention. Numerous variations and modifications possible. For example, while in some cases electrodes were designated as upper electrodes and lower electrodes, such a designation was for purposes of discussion, and shall not be read to require any relationship to gravity during surgical procedures. It is intended that the following claims be interpreted to embrace all such variations and modifications.
While preferred embodiments of this disclosure have been shown and described, modifications thereof can be made by one skilled in the art without departing from the scope or teaching herein. The embodiments described herein are exemplary only and are not limiting. Because many varying and different embodiments may be made within the scope of the present inventive concept, including equivalent structures, materials, or methods hereafter though of, and because many modifications may be made in the embodiments herein detailed in accordance with the descriptive requirements of the law, it is to be understood that the details herein are to be interpreted as illustrative and not in a limiting sense.
The present invention claims priority to U.S. Provisional Application No. 61/532,474, entitled Plasma Bipolar Forceps, filed Sep. 8, 2011, the complete disclosure of which is hereby incorporated by reference in its entirety for all purposes.
Number | Name | Date | Kind |
---|---|---|---|
2050904 | Talley | Aug 1936 | A |
2056377 | Wappler | Oct 1939 | A |
3633425 | Sanford | Jan 1972 | A |
3815604 | O'Malley et al. | Jun 1974 | A |
3828780 | Morrison, Jr. et al. | Aug 1974 | A |
3901242 | Storz | Aug 1975 | A |
3920021 | Hiltebrandt | Nov 1975 | A |
3939839 | Curtiss | Feb 1976 | A |
3970088 | Morrison | Jul 1976 | A |
4033351 | Hetzel | Jul 1977 | A |
4040426 | Morrison, Jr. | Aug 1977 | A |
4043342 | Morrison, Jr. | Aug 1977 | A |
4074718 | Morrison, Jr. | Feb 1978 | A |
4092986 | Schneiderman | Jun 1978 | A |
4116198 | Roos | Sep 1978 | A |
4181131 | Ogiu | Jan 1980 | A |
4184492 | Meinke et al. | Jan 1980 | A |
4202337 | Hren et al. | May 1980 | A |
4228800 | Degler, Jr. et al. | Oct 1980 | A |
4232676 | Herczog | Nov 1980 | A |
4248231 | Herczog et al. | Feb 1981 | A |
4301802 | Poler | Nov 1981 | A |
4326529 | Doss et al. | Apr 1982 | A |
4381007 | Doss | Apr 1983 | A |
4474179 | Koch | Oct 1984 | A |
4476862 | Pao | Oct 1984 | A |
4532924 | Auth et al. | Aug 1985 | A |
4548207 | Reimels | Oct 1985 | A |
4567890 | Ohta et al. | Feb 1986 | A |
4582057 | Auth et al. | Apr 1986 | A |
4590934 | Malis et al. | May 1986 | A |
4593691 | Lindstrom et al. | Jun 1986 | A |
4658817 | Hardy | Apr 1987 | A |
4660571 | Hess et al. | Apr 1987 | A |
4674499 | Pao | Jun 1987 | A |
4682596 | Bales et al. | Jul 1987 | A |
4706667 | Roos | Nov 1987 | A |
4709698 | Johnston et al. | Dec 1987 | A |
4727874 | Bowers et al. | Mar 1988 | A |
4765331 | Petruzzi et al. | Aug 1988 | A |
4785823 | Eggers et al. | Nov 1988 | A |
4805616 | Pao | Feb 1989 | A |
4823791 | D'Amelio et al. | Apr 1989 | A |
4832048 | Cohen | May 1989 | A |
4860752 | Turner | Aug 1989 | A |
4907589 | Cosman | Mar 1990 | A |
4920978 | Colvin | May 1990 | A |
4931047 | Broadwin et al. | Jun 1990 | A |
4936281 | Stasz | Jun 1990 | A |
4936301 | Rexroth et al. | Jun 1990 | A |
4943290 | Rexroth et al. | Jul 1990 | A |
4966597 | Cosman | Oct 1990 | A |
4967765 | Turner et al. | Nov 1990 | A |
4976711 | Parins et al. | Dec 1990 | A |
4979948 | Geddes et al. | Dec 1990 | A |
4998933 | Eggers et al. | Mar 1991 | A |
5007908 | Rydell | Apr 1991 | A |
5009656 | Reimels | Apr 1991 | A |
5035696 | Rydell | Jul 1991 | A |
5047026 | Rydell | Sep 1991 | A |
5047027 | Rydell | Sep 1991 | A |
5057105 | Malone et al. | Oct 1991 | A |
5057106 | Kasevich et al. | Oct 1991 | A |
5078716 | Doll | Jan 1992 | A |
5078717 | Parins et al. | Jan 1992 | A |
5080660 | Buelna | Jan 1992 | A |
5083565 | Parins | Jan 1992 | A |
5084044 | Quint | Jan 1992 | A |
5085659 | Rydell | Feb 1992 | A |
5088997 | Delahuerga et al. | Feb 1992 | A |
5098431 | Rydell | Mar 1992 | A |
5099840 | Goble | Mar 1992 | A |
5102410 | Dressel | Apr 1992 | A |
5108391 | Flachenecker et al. | Apr 1992 | A |
RE33925 | Bales et al. | May 1992 | E |
5112330 | Nishigaki et al. | May 1992 | A |
5122138 | Manwaring | Jun 1992 | A |
5125928 | Parins et al. | Jun 1992 | A |
5156151 | Imran | Oct 1992 | A |
5167659 | Ohtomo et al. | Dec 1992 | A |
5167660 | Altendorf | Dec 1992 | A |
5171311 | Rydell et al. | Dec 1992 | A |
5178620 | Eggers et al. | Jan 1993 | A |
5190517 | Zieve et al. | Mar 1993 | A |
5192280 | Parins | Mar 1993 | A |
5195959 | Smith | Mar 1993 | A |
5195968 | Lundquist et al. | Mar 1993 | A |
5196007 | Ellman | Mar 1993 | A |
5197466 | Marchosky et al. | Mar 1993 | A |
5197963 | Parins | Mar 1993 | A |
5207675 | Canady | May 1993 | A |
5217457 | Delahuerga et al. | Jun 1993 | A |
5217459 | Kamerling | Jun 1993 | A |
5249585 | Turner et al. | Oct 1993 | A |
5261410 | Alfano et al. | Nov 1993 | A |
5267994 | Gentelia et al. | Dec 1993 | A |
5267997 | Farin et al. | Dec 1993 | A |
5273524 | Fox et al. | Dec 1993 | A |
5277201 | Stern | Jan 1994 | A |
5281216 | Klicek | Jan 1994 | A |
5281218 | Imran | Jan 1994 | A |
5290282 | Casscells | Mar 1994 | A |
5300069 | Hunsberger et al. | Apr 1994 | A |
5306238 | Fleenor | Apr 1994 | A |
5312400 | Bales et al. | May 1994 | A |
5314406 | Arias et al. | May 1994 | A |
5324254 | Phillips | Jun 1994 | A |
5330470 | Hagen | Jul 1994 | A |
5334140 | Phillips | Aug 1994 | A |
5334183 | Wuchinich | Aug 1994 | A |
5334193 | Nardella | Aug 1994 | A |
5336220 | Ryan et al. | Aug 1994 | A |
5336443 | Odashima | Aug 1994 | A |
5342357 | Nardella | Aug 1994 | A |
5363861 | Edwards et al. | Nov 1994 | A |
5366443 | Eggers et al. | Nov 1994 | A |
5370675 | Edwards et al. | Dec 1994 | A |
5374261 | Yoon | Dec 1994 | A |
5375588 | Yoon | Dec 1994 | A |
5380277 | Phillips | Jan 1995 | A |
5380316 | Aita | Jan 1995 | A |
5383876 | Nardella | Jan 1995 | A |
5383917 | Desai et al. | Jan 1995 | A |
5389096 | Aita | Feb 1995 | A |
5395312 | Desai | Mar 1995 | A |
5395363 | Billings et al. | Mar 1995 | A |
5395368 | Ellman et al. | Mar 1995 | A |
5400267 | Denen et al. | Mar 1995 | A |
5401272 | Perkins | Mar 1995 | A |
5403311 | Abele et al. | Apr 1995 | A |
5417687 | Nardella et al. | May 1995 | A |
5419767 | Eggers et al. | May 1995 | A |
5423810 | Goble et al. | Jun 1995 | A |
5423811 | Imran et al. | Jun 1995 | A |
5423812 | Ellman et al. | Jun 1995 | A |
5423882 | Jackman et al. | Jun 1995 | A |
5436566 | Thompson et al. | Jul 1995 | A |
5437662 | Nardella | Aug 1995 | A |
5438302 | Goble | Aug 1995 | A |
5441499 | Fritzsch | Aug 1995 | A |
5451224 | Goble et al. | Sep 1995 | A |
5454809 | Janssen | Oct 1995 | A |
5456662 | Edwards et al. | Oct 1995 | A |
5458596 | Lax et al. | Oct 1995 | A |
5487757 | Truckai et al. | Jan 1996 | A |
5490850 | Ellman et al. | Feb 1996 | A |
5496312 | Klicek | Mar 1996 | A |
5496314 | Eggers | Mar 1996 | A |
5496317 | Goble et al. | Mar 1996 | A |
5505728 | Ellman et al. | Apr 1996 | A |
5505730 | Edwards | Apr 1996 | A |
5514130 | Baker | May 1996 | A |
5554152 | Aita | Sep 1996 | A |
5556397 | Long et al. | Sep 1996 | A |
5562503 | Ellman et al. | Oct 1996 | A |
5562703 | Desai | Oct 1996 | A |
5569242 | Lax et al. | Oct 1996 | A |
5571100 | Goble et al. | Nov 1996 | A |
5571101 | Ellman et al. | Nov 1996 | A |
5584872 | LaFontaine et al. | Dec 1996 | A |
5609151 | Mulier et al. | Mar 1997 | A |
5624439 | Edwards et al. | Apr 1997 | A |
5630812 | Ellman et al. | May 1997 | A |
5633578 | Eggers et al. | May 1997 | A |
5647869 | Goble et al. | Jul 1997 | A |
5658278 | Imran et al. | Aug 1997 | A |
5662680 | Desai | Sep 1997 | A |
5674191 | Edwards et al. | Oct 1997 | A |
5676693 | LaFontaine et al. | Oct 1997 | A |
5681282 | Eggers et al. | Oct 1997 | A |
5683366 | Eggers et al. | Nov 1997 | A |
5683386 | Ellman et al. | Nov 1997 | A |
5683387 | Garito et al. | Nov 1997 | A |
5688267 | Panescu et al. | Nov 1997 | A |
5695495 | Ellman et al. | Dec 1997 | A |
5697281 | Eggers et al. | Dec 1997 | A |
5697536 | Eggers et al. | Dec 1997 | A |
5697882 | Eggers et al. | Dec 1997 | A |
5697909 | Eggers et al. | Dec 1997 | A |
5700262 | Acosta et al. | Dec 1997 | A |
5707349 | Edwards | Jan 1998 | A |
5718702 | Edwards | Feb 1998 | A |
5725524 | Mulier et al. | Mar 1998 | A |
5728094 | Edwards | Mar 1998 | A |
5733282 | Ellman et al. | Mar 1998 | A |
5738114 | Edwards | Apr 1998 | A |
5743870 | Edwards | Apr 1998 | A |
5746224 | Edwards | May 1998 | A |
5749869 | Lindenmeier et al. | May 1998 | A |
5766153 | Eggers et al. | Jun 1998 | A |
5775338 | Hastings | Jul 1998 | A |
5776128 | Eggers | Jul 1998 | A |
5782828 | Chen et al. | Jul 1998 | A |
5800379 | Edwards | Sep 1998 | A |
5800429 | Edwards | Sep 1998 | A |
5807395 | Mulier et al. | Sep 1998 | A |
5810764 | Eggers et al. | Sep 1998 | A |
5810809 | Rydell | Sep 1998 | A |
5817049 | Edwards | Oct 1998 | A |
5820580 | Edwards et al. | Oct 1998 | A |
5823197 | Edwards | Oct 1998 | A |
5827277 | Edwards | Oct 1998 | A |
5836875 | Webster, Jr. | Nov 1998 | A |
5843019 | Eggers et al. | Dec 1998 | A |
5843021 | Edwards et al. | Dec 1998 | A |
5843077 | Edwards | Dec 1998 | A |
5860951 | Eggers | Jan 1999 | A |
5860974 | Abele | Jan 1999 | A |
5860975 | Goble et al. | Jan 1999 | A |
5871469 | Eggers et al. | Feb 1999 | A |
5873855 | Eggers et al. | Feb 1999 | A |
5879349 | Edwards | Mar 1999 | A |
5885277 | Korth | Mar 1999 | A |
5888198 | Eggers et al. | Mar 1999 | A |
5891095 | Eggers et al. | Apr 1999 | A |
5891134 | Goble et al. | Apr 1999 | A |
5897553 | Mulier | Apr 1999 | A |
5902272 | Eggers et al. | May 1999 | A |
5916214 | Cosio et al. | Jun 1999 | A |
5919190 | Vandusseldorp | Jul 1999 | A |
5921983 | Shannon, Jr. | Jul 1999 | A |
5944715 | Goble et al. | Aug 1999 | A |
5954716 | Sharkey et al. | Sep 1999 | A |
5988171 | Sohn et al. | Nov 1999 | A |
6004319 | Goble et al. | Dec 1999 | A |
6006755 | Edwards | Dec 1999 | A |
6009877 | Edwards | Jan 2000 | A |
6013076 | Goble et al. | Jan 2000 | A |
6015406 | Goble et al. | Jan 2000 | A |
6024733 | Eggers et al. | Feb 2000 | A |
6026816 | McMillan et al. | Feb 2000 | A |
6027501 | Goble et al. | Feb 2000 | A |
6032674 | Eggers et al. | Mar 2000 | A |
6039734 | Goble et al. | Mar 2000 | A |
6044846 | Edwards | Apr 2000 | A |
6047700 | Eggers et al. | Apr 2000 | A |
6053172 | Hovda et al. | Apr 2000 | A |
6056746 | Goble et al. | May 2000 | A |
6063079 | Hovda et al. | May 2000 | A |
6066134 | Eggers et al. | May 2000 | A |
6066139 | Ryan et al. | May 2000 | A |
6068628 | Fanton et al. | May 2000 | A |
6071281 | Burnside et al. | Jun 2000 | A |
6073052 | Zelickson et al. | Jun 2000 | A |
6074386 | Goble et al. | Jun 2000 | A |
6086585 | Hovda et al. | Jul 2000 | A |
6090106 | Goble et al. | Jul 2000 | A |
6093186 | Goble et al. | Jul 2000 | A |
6102046 | Weinstein et al. | Aug 2000 | A |
6105581 | Eggers et al. | Aug 2000 | A |
6109268 | Thapliyal et al. | Aug 2000 | A |
6117109 | Eggers et al. | Sep 2000 | A |
6126682 | Sharkey et al. | Oct 2000 | A |
6142992 | Cheng et al. | Nov 2000 | A |
6149620 | Baker et al. | Nov 2000 | A |
6159194 | Eggers et al. | Dec 2000 | A |
6159208 | Hovda et al. | Dec 2000 | A |
6168593 | Sharkey et al. | Jan 2001 | B1 |
6174309 | Wrublewski et al. | Jan 2001 | B1 |
6179824 | Eggers et al. | Jan 2001 | B1 |
6179836 | Eggers et al. | Jan 2001 | B1 |
6183469 | Thapliyal et al. | Feb 2001 | B1 |
6190381 | Olsen et al. | Feb 2001 | B1 |
6203542 | Ellsberry et al. | Mar 2001 | B1 |
6210402 | Olsen et al. | Apr 2001 | B1 |
6210405 | Goble et al. | Apr 2001 | B1 |
6224592 | Eggers et al. | May 2001 | B1 |
6228078 | Eggers | May 2001 | B1 |
6228081 | Goble | May 2001 | B1 |
6234178 | Goble et al. | May 2001 | B1 |
6235020 | Cheng et al. | May 2001 | B1 |
6237604 | Burnside et al. | May 2001 | B1 |
6238391 | Olsen et al. | May 2001 | B1 |
6254600 | Willink et al. | Jul 2001 | B1 |
6258086 | Ashley et al. | Jul 2001 | B1 |
6261286 | Goble et al. | Jul 2001 | B1 |
6261311 | Sharkey et al. | Jul 2001 | B1 |
6264652 | Eggers et al. | Jul 2001 | B1 |
6270460 | McCartan et al. | Aug 2001 | B1 |
6270476 | Santoianni et al. | Aug 2001 | B1 |
6277112 | Underwood et al. | Aug 2001 | B1 |
6280441 | Ryan | Aug 2001 | B1 |
6283961 | Underwood et al. | Sep 2001 | B1 |
6293942 | Goble et al. | Sep 2001 | B1 |
6296636 | Cheng et al. | Oct 2001 | B1 |
6296638 | Davison et al. | Oct 2001 | B1 |
6306134 | Goble et al. | Oct 2001 | B1 |
6308089 | von der Rur et al. | Oct 2001 | B1 |
6309387 | Eggers et al. | Oct 2001 | B1 |
6312408 | Eggers et al. | Nov 2001 | B1 |
6322549 | Eggers et al. | Nov 2001 | B1 |
6355032 | Hovda et al. | Mar 2002 | B1 |
6363937 | Hovda et al. | Apr 2002 | B1 |
6364877 | Goble et al. | Apr 2002 | B1 |
6379350 | Sharkey et al. | Apr 2002 | B1 |
6379351 | Thapliyal et al. | Apr 2002 | B1 |
6387093 | Ellman et al. | May 2002 | B1 |
6391025 | Weinstein et al. | May 2002 | B1 |
6411852 | Danek et al. | Jun 2002 | B1 |
6413254 | Hissong et al. | Jul 2002 | B1 |
6416491 | Edwards et al. | Jul 2002 | B1 |
6416507 | Eggers et al. | Jul 2002 | B1 |
6416508 | Eggers et al. | Jul 2002 | B1 |
6416509 | Goble et al. | Jul 2002 | B1 |
6427089 | Knowlton | Jul 2002 | B1 |
6432103 | Ellsberry et al. | Aug 2002 | B1 |
6464699 | Swanson | Oct 2002 | B1 |
6468274 | Alleyne et al. | Oct 2002 | B1 |
6468275 | Wampler et al. | Oct 2002 | B1 |
6482201 | Olsen et al. | Nov 2002 | B1 |
6491690 | Goble et al. | Dec 2002 | B1 |
6517498 | Burbank et al. | Feb 2003 | B1 |
6530922 | Cosman | Mar 2003 | B2 |
6530924 | Ellman et al. | Mar 2003 | B1 |
6551032 | Nolan et al. | Apr 2003 | B1 |
6572613 | Ellman et al. | Jun 2003 | B1 |
6578579 | Burnside | Jun 2003 | B2 |
6589235 | Wong et al. | Jul 2003 | B2 |
6589237 | Woloszko et al. | Jul 2003 | B2 |
6602248 | Sharps et al. | Aug 2003 | B1 |
6620156 | Garito et al. | Sep 2003 | B1 |
6632193 | Davison et al. | Oct 2003 | B1 |
6632220 | Eggers et al. | Oct 2003 | B1 |
6702810 | McClurken et al. | Mar 2004 | B2 |
6736810 | Hoey et al. | May 2004 | B2 |
6746447 | Davison et al. | Jun 2004 | B2 |
6749604 | Eggers et al. | Jun 2004 | B1 |
6749608 | Garito et al. | Jun 2004 | B2 |
6770071 | Woloszko et al. | Aug 2004 | B2 |
6780178 | Palanker et al. | Aug 2004 | B2 |
6780180 | Goble et al. | Aug 2004 | B1 |
6802842 | Ellman et al. | Oct 2004 | B2 |
6837887 | Woloszko et al. | Jan 2005 | B2 |
6837888 | Ciarrocca et al. | Jan 2005 | B2 |
6896674 | Woloszko et al. | May 2005 | B1 |
6920883 | Bessette et al. | Jul 2005 | B2 |
6929640 | Underwood et al. | Aug 2005 | B1 |
6942662 | Goble et al. | Sep 2005 | B2 |
6949096 | Davison et al. | Sep 2005 | B2 |
6955172 | Nelson et al. | Oct 2005 | B2 |
6960204 | Eggers et al. | Nov 2005 | B2 |
6974453 | Woloszko et al. | Dec 2005 | B2 |
6984231 | Goble et al. | Jan 2006 | B2 |
6991631 | Woloszko et al. | Jan 2006 | B2 |
7004941 | Tvinnereim et al. | Feb 2006 | B2 |
7041102 | Truckai et al. | May 2006 | B2 |
7066936 | Ryan | Jun 2006 | B2 |
7070596 | Woloszko et al. | Jul 2006 | B1 |
7090672 | Underwood et al. | Aug 2006 | B2 |
7094215 | Davison et al. | Aug 2006 | B2 |
7104986 | Hovda et al. | Sep 2006 | B2 |
7131969 | Hovda et al. | Nov 2006 | B1 |
7160296 | Pearson et al. | Jan 2007 | B2 |
7169143 | Eggers et al. | Jan 2007 | B2 |
7179255 | Lettice et al. | Feb 2007 | B2 |
7186234 | Dahla et al. | Mar 2007 | B2 |
7192428 | Eggers et al. | Mar 2007 | B2 |
7195630 | Ciarrocca | Mar 2007 | B2 |
7201750 | Eggers et al. | Apr 2007 | B1 |
7217268 | Eggers et al. | May 2007 | B2 |
7235073 | Levine | Jun 2007 | B2 |
7241293 | Davison | Jul 2007 | B2 |
7270658 | Woloszko et al. | Sep 2007 | B2 |
7270659 | Ricart et al. | Sep 2007 | B2 |
7270661 | Dahla et al. | Sep 2007 | B2 |
7276063 | Davison et al. | Oct 2007 | B2 |
7297143 | Woloszko et al. | Nov 2007 | B2 |
7297145 | Woloszko et al. | Nov 2007 | B2 |
7318823 | Sharps et al. | Jan 2008 | B2 |
7331956 | Hovda et al. | Feb 2008 | B2 |
RE40156 | Sharps et al. | Mar 2008 | E |
7357798 | Sharps et al. | Apr 2008 | B2 |
7387625 | Hovda et al. | Jun 2008 | B2 |
7419488 | Ciarrocca et al. | Sep 2008 | B2 |
7429260 | Underwood et al. | Sep 2008 | B2 |
7429262 | Woloszko et al. | Sep 2008 | B2 |
7435247 | Woloszko et al. | Oct 2008 | B2 |
7442191 | Hovda et al. | Oct 2008 | B2 |
7445618 | Eggers et al. | Nov 2008 | B2 |
7449021 | Underwood et al. | Nov 2008 | B2 |
7462178 | Woloszko et al. | Dec 2008 | B2 |
7468059 | Eggers et al. | Dec 2008 | B2 |
7491200 | Underwood et al. | Feb 2009 | B2 |
7507236 | Eggers et al. | Mar 2009 | B2 |
7572251 | Davison et al. | Aug 2009 | B1 |
7632267 | Dahla | Dec 2009 | B2 |
7691101 | Davison et al. | Apr 2010 | B2 |
7704249 | Woloszko et al. | Apr 2010 | B2 |
7708733 | Sanders et al. | May 2010 | B2 |
7824398 | Woloszko et al. | Nov 2010 | B2 |
7879034 | Woloszko et al. | Feb 2011 | B2 |
7892230 | Woloszko et al. | Feb 2011 | B2 |
7901403 | Woloszko et al. | Mar 2011 | B2 |
8012153 | Woloszko et al. | Sep 2011 | B2 |
8114071 | Woloszko et al. | Feb 2012 | B2 |
8469991 | Kerr | Jun 2013 | B2 |
8568405 | Cox et al. | Oct 2013 | B2 |
8747401 | Gonzalez et al. | Jun 2014 | B2 |
9011428 | Nguyen et al. | Apr 2015 | B2 |
20020026186 | Woloszko et al. | Feb 2002 | A1 |
20020029036 | Goble et al. | Mar 2002 | A1 |
20020049438 | Sharkey et al. | Apr 2002 | A1 |
20020111608 | Baerveldt | Aug 2002 | A1 |
20020120259 | Lettice et al. | Aug 2002 | A1 |
20030013986 | Saadat | Jan 2003 | A1 |
20030014050 | Sharkey et al. | Jan 2003 | A1 |
20030088245 | Woloszko et al. | May 2003 | A1 |
20030097129 | Davison et al. | May 2003 | A1 |
20030158545 | Hovda et al. | Aug 2003 | A1 |
20030171743 | Tasto et al. | Sep 2003 | A1 |
20030208196 | Stone | Nov 2003 | A1 |
20030212396 | Eggers et al. | Nov 2003 | A1 |
20040054366 | Davison et al. | Mar 2004 | A1 |
20040116922 | Hovda et al. | Jun 2004 | A1 |
20040127893 | Hovda | Jul 2004 | A1 |
20040230190 | Dahla et al. | Nov 2004 | A1 |
20050004634 | Ricart et al. | Jan 2005 | A1 |
20050043728 | Ciarrocca | Feb 2005 | A1 |
20050119650 | Sanders et al. | Jun 2005 | A1 |
20050261754 | Woloszko et al. | Nov 2005 | A1 |
20050283149 | Thorne et al. | Dec 2005 | A1 |
20050288665 | Woloszko et al. | Dec 2005 | A1 |
20060036237 | Davison et al. | Feb 2006 | A1 |
20060095031 | Ormsby | May 2006 | A1 |
20060129145 | Woloszko et al. | Jun 2006 | A1 |
20060189971 | Tasto et al. | Aug 2006 | A1 |
20060253117 | Hovda et al. | Nov 2006 | A1 |
20060259025 | Dahla | Nov 2006 | A1 |
20060259031 | Carmel et al. | Nov 2006 | A1 |
20070010808 | Dahla | Jan 2007 | A1 |
20070106288 | Woloszko et al. | May 2007 | A1 |
20070149966 | Dahla et al. | Jun 2007 | A1 |
20070161981 | Sanders et al. | Jul 2007 | A1 |
20070208335 | Woloszko et al. | Sep 2007 | A1 |
20070282323 | Woloszko et al. | Dec 2007 | A1 |
20080200972 | Rittman et al. | Aug 2008 | A1 |
20090030414 | Bayat | Jan 2009 | A1 |
20100204690 | Bigley et al. | Aug 2010 | A1 |
20120101494 | Cadouri et al. | Apr 2012 | A1 |
20120191089 | Gonzalez et al. | Jul 2012 | A1 |
20120203219 | Evans et al. | Aug 2012 | A1 |
20120226273 | Nguyen et al. | Sep 2012 | A1 |
20130197506 | Evans et al. | Aug 2013 | A1 |
20140200581 | Aluru et al. | Jul 2014 | A1 |
20150196346 | Nguyen et al. | Jul 2015 | A1 |
Number | Date | Country |
---|---|---|
12222065 | Jul 1999 | CN |
3930451 | Mar 1991 | DE |
202014002299.20 | Jul 2014 | DE |
102014003645.00 | Sep 2014 | DE |
0509670 | Oct 1992 | EP |
0703461 | Mar 1996 | EP |
0740926 | Nov 1996 | EP |
0754437 | Jan 1997 | EP |
0694290 | Nov 2000 | EP |
0959787 | Oct 2007 | EP |
2198799 | Jun 2010 | EP |
2313949 | Jan 1977 | FR |
2 308 979 | Jul 1997 | GB |
2 308 980 | Jul 1997 | GB |
2 308 981 | Jul 1997 | GB |
2 327 350 | Jan 1999 | GB |
2 327 351 | Jan 1999 | GB |
2 327 352 | Jan 1999 | GB |
2477353 | Aug 2011 | GB |
2479582 | Oct 2011 | GB |
2488039 | Aug 2012 | GB |
2522352 | Feb 2015 | GB |
57-57802 | Apr 1982 | JP |
57-117843 | Jul 1982 | JP |
58-13213 | Jan 1983 | JP |
10-43198 | Feb 1998 | JP |
9003152 | Apr 1990 | WO |
9007303 | Jul 1990 | WO |
9221278 | Dec 1992 | WO |
9313816 | Jul 1993 | WO |
9320747 | Oct 1993 | WO |
9404220 | Mar 1994 | WO |
9408654 | Apr 1994 | WO |
9410924 | May 1994 | WO |
9426228 | Nov 1994 | WO |
9534259 | Dec 1995 | WO |
9600042 | Jan 1996 | WO |
9623449 | Aug 1996 | WO |
9637156 | Nov 1996 | WO |
9639914 | Dec 1996 | WO |
9700646 | Jan 1997 | WO |
9700647 | Jan 1997 | WO |
9715237 | May 1997 | WO |
9718765 | May 1997 | WO |
9724073 | Jul 1997 | WO |
9724074 | Jul 1997 | WO |
9724993 | Jul 1997 | WO |
9724994 | Jul 1997 | WO |
9730644 | Aug 1997 | WO |
9730645 | Aug 1997 | WO |
9730646 | Aug 1997 | WO |
9730647 | Aug 1997 | WO |
9741785 | Nov 1997 | WO |
9741786 | Nov 1997 | WO |
9741787 | Nov 1997 | WO |
9741788 | Nov 1997 | WO |
9743969 | Nov 1997 | WO |
9743970 | Nov 1997 | WO |
9743972 | Nov 1997 | WO |
9743973 | Nov 1997 | WO |
9744092 | Nov 1997 | WO |
9748345 | Dec 1997 | WO |
9748346 | Dec 1997 | WO |
9803117 | Jan 1998 | WO |
9807468 | Feb 1998 | WO |
9827879 | Jul 1998 | WO |
9827880 | Jul 1998 | WO |
9908613 | Feb 1999 | WO |
9909919 | Mar 1999 | WO |
9917690 | Apr 1999 | WO |
9930655 | Jun 1999 | WO |
9951155 | Oct 1999 | WO |
9951158 | Oct 1999 | WO |
0062698 | Oct 2000 | WO |
0187154 | May 2001 | WO |
0236028 | May 2002 | WO |
02085230 | Oct 2002 | WO |
03005882 | Jan 2003 | WO |
03024305 | Mar 2003 | WO |
03047446 | Jun 2003 | WO |
03068095 | Aug 2003 | WO |
2004050171 | Jun 2004 | WO |
2005125287 | Dec 2005 | WO |
2006002337 | Jan 2006 | WO |
2006125007 | Nov 2006 | WO |
Entry |
---|
Barry et al., “The Effect of Radiofrequency-generated Thermal Energy on the Mechanical and Histologic Characteristics of the Arterial Wall in Vivo: Implications of Radiofrequency Angioplasty” American Heart Journal vol. 117, pp. 332-341, 1982. |
BiLAP Generator Settings, Jun. 1991. |
BiLAP IFU 910026-001 Rev A for BiLAP Model 3525, J-Hook, 4 pgs, May 20, 1991. |
BiLAP IFU 910033-002 Rev A for BiLAP Model 3527, L-Hook; BiLAP Model 3525, J-Hook; BiLAP Model 3529, High Angle, 2 pgs, Nov. 30, 1993. |
Codman & Shurtleff, Inc. “The Malis Bipolar Coagulating and Bipolar Cutting System CMC-II” brochure, early, 2 pgs, 1991. |
Codman & Shurtleff, Inc. “The Malis Bipolar Electrosurgical System CMC—III Instruction Manual” , 15 pgs, Jul. 1991. |
Cook et al., “Therapeutic Medical Devices: Application and Design”, Prentice Hall, Inc., 3pgs, 1982. |
Dennis et al. “Evolution of Electrofulguration in Control of Bleeding of Experimental Gastric Ulcers,” Digestive Diseases and Sciences, vol. 24, No. 11, 845-848, Nov. 1979. |
Dobbie, A.K., “The Electrical Aspects of Surgical Diathermy, Bio Medical Engineering” Bio-Medical Engineering vol. 4, pp. 206-216, May 1969. |
Elsasser, V.E. et al., “An Instrument for Transurethral Resection without Leakage of Current” Acta Medicotechnica vol. 24, No. 4, pp. 129-134, 1976. |
Geddes, “Medical Device Accidents: With Illustrative Cases” CRC Press, 3 pgs, 1998. |
Honig, W., “The Mechanism of Cutting in Electrosurgery” IEEE pp. 58-65, 1975. |
Kramolowsky et al. “The Urological App of Electorsurgery” J. of Urology vol. 146, pp. 669-674, 1991. |
Kramolowsky et al. “Use of 5F Bipolar Electrosurgical Probe in Endoscopic Urological Procedures” J. of Urology vol. 143, pp. 275-277, 1990. |
Lee, B et al. “Thermal Compression and Molding of Artherosclerotic Vascular Tissue with Use” JACC vol. 13(5), pp. 1167-1171, 1989. |
Letter from Department of Health to Jerry Malis dated Jan. 24, 1991, 3 pgs. |
Letter from Department of Health to Jerry Malis dated Jul. 25, 1985, 1 pg. |
Letter from Jerry Malis to FDA dated Jul. 25, 1985, 2 pgs. |
Lu, et al., “Electrical Thermal Angioplasty: Catheter Design Features, In Vitro Tissue Ablation Studies and In Vitro Experimental Findings,” Am J. Cardiol vol. 60, pp. 1117-1122, Nov. 1, 1987. |
Malis, L., “Electrosurgery, Technical Note,” J. Neursurg., vol. 85, pp. 970-975, Nov. 1996. |
Malis, L., “Excerpted from a seminar by Leonard I. Malis, M.D. at the 1995 American Association of Neurological Surgeons Meeting,” 1pg, 1995. |
Malis, L., “Instrumentation for Microvascular Neurosurgery” Cerebrovascular Surgery, vol. 1, pp. 245-260, 1985. |
Malis, L., “New Trends in Microsurgery and Applied Technology,” Advanced Technology in Neurosurgery, pp. 1-16, 1988. |
Malis, L., “The Value of Irrigation During Bipolar Coagulation” See ARTC 21602, 1 pg, Apr. 9, 1993. |
Nardella, P.C., SPIE 1068: pp. 42-49, Radio Frequency Energy and Impedance Feedback, 1989. |
O'Malley, Schaum's Outline of Theory and Problems of Basic Circuit Analysis, McGraw-Hill, 2nd Ed., pp. 3-5, 1992. |
Olsen MD, Bipolar Laparoscopic Cholecstectomy Lecture (marked confidential), 12 pgs, Oct. 7, 1991. |
Pearce, John A. “Electrosurgery”, pp. 17, 69-75, 87, John Wiley & Sons, New York, 1986. |
Pearce, John A., “Electrosurgery”, Handbook of Biomedical Engineering, chapter 3, Academic Press Inc., N.Y., pp. 98-113, 1988. |
Piercey et al., “Electrosurgical Treatment of Experimental Bleeding Canine Gastric Ulcers” Gastroenterology vol. 74(3), pp. 527-534, 1978. |
Protell et al., “Computer-Assisted Electrocoagulation: Bipolar v. Monopolar in the Treatment of Experimental Canine Gastric Ulcer Bleeding,” Gastroenterology vol. 80, No. 3, pp. 451-455, 1981. |
Ramsey et al., “A Comparison of Bipolar and Monopolar Diathermy Probes in Experimental Animals”, Urological Research vol. 13, pp. 99-102, 1985. |
Selikowitz et al., “Electric Current and Voltage Recordings on the Myocardium During Electrosurgical Procedures in Canines,” Surgery, Gynecology & Obstetrics, vol. 164, pp. 219-224, Mar. 1987. |
Shuman, “Bipolar Versus Monopolar Electrosurgery: Clinical Applications,” Dentistry Today, vol. 20, No. 12, 7 pgs, Dec. 2001. |
Slager et al. “Spark Erosion of Arteriosclerotic Plaques” Z. Kardiol. 76:Suppl. 6, pp. 67-71, 1987. |
Slager et al. “Vaporization of Atherosclerotice Plaques by Spark Erosion” JACC 5(6): pp. 1382-1386, Jun. 1985. |
Stoffels, E. et al., “Investigation on the Interaction Plasma-Bone Tissue”, E-MRS Spring Meeting, 1 pg, Jun. 18-21, 2002. |
Stoffels, E. et al., “Biomedical Applications of Plasmas”, Tutorial presented prior to the 55th Gaseous Electronics Conference in Minneapolis, MN, 41 pgs, Oct. 14, 2002. |
Stoffels, E. et al., “Plasma Interactions with Living Cells”, Eindhoven University of Technology, 1 pg, 2002. |
Stoffels, E. et al., “Superficial Treatment of Mammalian Cells using Plasma Needle”, J. Phys. D: Appl. Phys. 26, pp. 2908-2913, Nov. 19, 2003. |
Stoffels, E. et al., “Plasma Needle”, Eindhoven University of Technology, 1 pg, Nov. 28, 2003. |
Stoffels, E. et al., “Plasma Physicists Move into Medicine”, Physicsweb, 1 pg, Nov. 2003. |
Stoffels, E. et al., “Plasma Treated Tissue Engineered Skin to Study Skin Damage”, Biomechanics and Tissue Engineering, Materials Technology, 1 pg, 2003. |
Stoffels, E. et al., “Plasma Treatment of Dental Cavities: A Feasibility Study”, IEEE Transaction on Plasma Science, vol. 32, No. 4, pp. 1540-1542, Aug. 2004. |
Stoffels, E. et al., “The Effects of UV Irradiation and Gas Plasma Treatment on Living Mammalian Cells and Bacteria: A Comparative Approach”, IEEE Transaction on Plasma Science, vol. 32, No. 4, pp. 1544-1550, Aug. 2004. |
Stoffels, E. et al., “Electrical and Optical Characterization of the Plasma Needle”, New Journal of Physics 6, pp. 1-14, Oct. 28, 2004. |
Stoffels, E. et al., “Where Plasma Meets Plasma”, Eindhoven University of Technology, 23 pgs, 2004. |
Stoffels, E. et al., “Gas Plasma effects on Living Cells”, Physica Scripta, T107, pp. 79-82, 2004. |
Stoffels, E. et al., “Plasma Treatment of Mammalian Vascular Cells: A Quantitative Description”, IEEE Transaction on Plasma Science, vol. 33, No. 2, pp. 771-775, Apr. 2005. |
Stoffels, E. et al., “Deactivation of Escherichia coli by the Plasma Needle”, J. Phys. D: Appl. Phys. 38, pp. 1716-1721, May 20, 2005. |
Stoffels, E. et al., “Development of a Gas Plasma Catheter for Gas Plasma Surgery”, XXVIIth ICPIG, Endoven University of Technology, pp. 18-22, Jul. 2005. |
Stoffels, E. et al., “Development of a Smart Positioning Sensor for the Plasma Needle”, Plasma Sources Sci. Technol. 15, pp. 582-589, Jun. 27, 2006. |
Stoffels, E. et al., Killing of S. Mutans Bacteria Using a Plasma Needle at Atmospheric Pressure, IEEE Transaction on Plasma Science, vol. 34, No. 4, pp. 1317-1324, Aug. 2006. |
Stoffels, E. et al., “Plasma-Needle Treatment of Substrates with Respect to Wettability and Growth of Excherichia coli and Streptococcus mutans”, IEEE Transaction on Plasma Science, vol. 34, No. 4, pp. 1325-1330, Aug. 2006. |
Stoffels, E. et al., “Reattachment and Apoptosis after Plasma-Needle Treatment of Cultured Cells”, IEEE Transaction on Plasma Science, vol. 34, No. 4, pp. 1331-1336, Aug. 2006. |
Stoffels, E. et al., “UV Excimer Lamp Irradiation of Fibroblasts: The Influence on Antioxidant Homostasis”, IEEE Transaction on Plasma Science, vol. 34, No. 4, pp. 1359-1364, Aug. 2006. |
Stoffels, E. et al., “Plasma Needle for In Vivo Medical Treatment: Recent Developments and Perspectives”, Plasma Sources Sci. Technol. 15, pp. S169-S180, Oct. 6, 2006. |
Swain, C.P., et al., “Which Electrode, A Comparison of four endoscopic methods of electrocoagulation in experimental bleeding ulcers” Gut vol. 25, pp. 1424-1431, 1987. |
Tucker, R. et al., Abstract P14-11, p. 248, “A Bipolar Electrosurgical Turp Loop”, Nov. 1989. |
Tucker, R. et al. “A Comparison of Urologic Application of Bipolar Versus Monopolar Five French Electrosurgical Probes” J. of Urology vol. 141, pp. 662-665, 1989. |
Tucker, R. et al. “In vivo effect of 5 French Bipolar and Monopolar Electrosurgical Probes on the Porcine Bladder” Urological Research vol. 18, pp. 291-294, 1990. |
Tucker, R. et al., “Demodulated Low Frequency Currents from Electrosurgical Procedures,” Surgery, Gynecology and Obstetrics, 159:39-43, 1984. |
Tucker et al. “The interaction between electrosurgical generators, endoscopic electrodes, and tissue,” Gastrointestinal Endoscopy, vol. 38, No. 2, pp. 118-122, 1992. |
Valley Forge Scientific Corp., “Summary of Safety and Effective Information from 510K”, 2pgs, 1991. |
Valley Forge's New Products, Clinica, 475, 5, Nov. 6, 1991. |
Valleylab SSE2L Instruction Manual, 11 pgs, Jan. 6, 1983. |
Valleylab, Inc. “Valleylab Part No. 945 100 102 A” Surgistat Service Manual, pp. 1-46, Jul. 1988. |
Wattiez, Arnaud et al., “Electrosurgery in Operative Endoscopy,” Electrosurgical Effects, Blackwell Science, pp. 85-93, 1995. |
Wyeth, “Electrosurgical Unit” pp. 1181-1202, 2000. |
Rand et al., “Effect of Elecctrocautery on Fresh Human Articular Cartilage”, J. Arthro. Surg., vol. 1, pp. 242-246, 1985. |
European Search Report for EP00123324.6 4 pgs, Mailed Jan. 16, 2001. |
European Search Report for EP00928246 4 pgs, Mailed Mar. 7, 2008. |
European Search Report for EP09153983 9 pgs, Mailed Apr. 1, 2009. |
European Search Report for EP98964730.0 3 pgs, Mailed Nov. 20, 2000. |
European Search Report for EP99922855.4 3 pgs, Aug. 2, 2001. |
European Search Report for EP05762588 3 pgs, Apr. 12, 2010. |
European Search Report for EP06760025.4 5 pgs, Nov. 10, 2010. |
PCT International Preliminary Examination Report for PCT/US00/10674 4pgs, Mailed Mar. 7, 2001. |
PCT International Preliminary Examination Report for PCT/US98/26624 4pgs, Mailed Oct. 12, 1999. |
PCT International Preliminary Examination Report for PCT/US99/10062 3pgs, Jun. 20, 2000. |
PCT International Preliminary Report on Patentability for PCT/US05/22373 4pgs, Dec. 28, 2006. |
PCT International Preliminary Report on Patentability for PCT/US06/19095 6pgs, Nov. 20, 2007. |
PCT International Search Report for PCT/US00/10674 1 pg, Mailed Jul. 27, 2000. |
PCT International Search Report for PCT/US03/38782 1 pg, Mailed Jun. 30, 2004. |
PCT International Search Report for PCT/US05/22373 1 pg, Mailed Oct. 3, 2006. |
PCT International Search Report for PCT/US06/19095 2 pgs, Mailed Oct. 4, 2007. |
PCT International Search Report for PCT/US96/08077 1 page, Mailed Sep. 16, 1996. |
PCT International Search Report for PCT/US98/26624 1 page, Mailed Mar. 3, 1999. |
PCT International Search Report for PCT/US99/10062 1 pg, Mailed Aug. 23, 1999. |
UK Search Report for GB1111622.5 4pgs, Mailed Oct. 26, 2011. |
UK Search Report for GB1202275.2 7pgs May 11, 2012. |
UK Search Report for GB1202275.2 5pgs Sep. 12, 2014. |
UK Combined Search and Exam Report for GB1404394.7 6pgs Sep. 17, 2014. |
CN First OA for CN app No. 201410129644.0 dated Sep. 2, 2015, 28 pages, Sep. 2, 2015. |
Number | Date | Country | |
---|---|---|---|
20130066317 A1 | Mar 2013 | US |
Number | Date | Country | |
---|---|---|---|
61532474 | Sep 2011 | US |